Select Language

VSV-G Protein

Product Inquiry

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
SHR-1918	SHR-1918; SHR1918	Phase 3 Clinical		Homozygous familial hypercholesterolemia; Hyperlipidemias	Details
Zodasiran	ARO-ANG3; ARO-ANG33; VSA-003 (Arrowhead Pharmaceuticals)	Phase 3 Clinical	Roche Ltd	Hypertriglyceridemia; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Dyslipidemias; Hyperlipoproteinemia Type II	Details
LNA-043	LNA-043	Phase 2 Clinical	Novartis Pharma Ag	Knee Injuries; Osteoarthritis, Knee; Osteoarthritis	Details
Vupanorsen	ISIS-703802; PF-07285557	Phase 2 Clinical	Ionis Pharmaceuticals Inc	Hypertriglyceridemia; Homozygous familial hypercholesterolemia; Diabetes Mellitus, Type 2; Metabolic Dysfunction-Associated Steatotic Liver Disease; Hyperlipoproteinemia Type I; Hyperlipoproteinemias; Dyslipidemias; Cardiovascular Diseases; Hyperlipidemias; Hyperlipoproteinemia Type II	Details
LY-3561774	LY-3561774; DCR-CM-1; DCR-CM1	Phase 2 Clinical	Dicerna Pharmaceuticals Inc	Metabolic Diseases; Dyslipidemias; Hyperlipoproteinemias; Cardiovascular Diseases; Lipid Metabolism Disorders	Details
LY-3475766	LY-3475766	Phase 1 Clinical	Eli Lilly And Company	Dyslipidemias	Details
JS-401	JS-401	Phase 1 Clinical	Shanghai Junshi Biological Engineering Co Ltd	Hyperlipidemias	Details
NN-6491	NN6491; NN-6491	Phase 1 Clinical	Novo Nordisk A/S	Cardiovascular Diseases	Details
AZD-1705	AZD1705; AZD-1705	Phase 1 Clinical	Parexel, Astrazeneca Plc	Cardiovascular Diseases	Details

English Name	Research Code	Highest Development Stage	Company	Earliest Brand Name	Earliest Approval Country	Earliest Indication	Earliest Approval Company	Earliest Approval Date	Indication	Clinical Trial
Evinacumab	REGN-1500	Approved		Evkeeza	United States	Hypercholesterolemia; Homozygous familial hypercholesterolemia	Regeneron Pharmaceuticals Inc	2021-02-11	Homozygous familial hypercholesterolemia; Hypertriglyceridemia; Hypercholesterolemia; Metabolic Diseases	Details